Japanese Pharmaceuticals & Biotech Most Popular Stocks

Chugai Pharmaceutical

Market Cap: JP¥14.3t

Engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally.

Takeda Pharmaceutical

Market Cap: JP¥9.1t

Engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan and internationally.

Otsuka Holdings

Market Cap: JP¥5.6t

Engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide.

Daiichi Sankyo Company

Market Cap: JP¥5.1t

Manufactures and sells pharmaceutical products in Japan, the United States, Europe, and internationally.

Astellas Pharma

Market Cap: JP¥4.7t

Manufactures, markets, imports, and exports pharmaceuticals in Japan and internationally.

Shionogi

Market Cap: JP¥2.9t

Engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan and internationally.

Eisai

Market Cap: JP¥1.4t

Engages in the research and development, manufacture, sale, and import and export of pharmaceuticals in India.

Kyowa Kirin

Market Cap: JP¥1.3t

Engages in the research, development, manufacturing, and marketing of pharmaceuticals in Japan, the Americas, Europe, Asia, and internationally.

Ono Pharmaceutical

Market Cap: JP¥1.2t

Produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide.

Sumitomo Pharma

Market Cap: JP¥810.5b

Manufactures, purchases, and sells pharmaceutical products for medical treatment in Japan, North America, and Asia.

Santen Pharmaceutical

Market Cap: JP¥587.5b

Engages in the research and development, manufacturing, and marketing of pharmaceuticals and medical devices in Japan, China, Asia, Europe, the Middle East, Africa, and internationally.

Hisamitsu Pharmaceutical

Market Cap: JP¥423.8b

Manufactures and sells pharmaceuticals in Japan.

Nippon Shinyaku

Market Cap: JP¥347.2b

Manufactures and sells pharmaceuticals and foodstuffs in Japan and internationally.

Tsumura

Market Cap: JP¥281.7b

Engages in the production and sale of Kampo extract intermediates and granular Kampo formulations in Japan and internationally.

Sawai Group Holdings

Market Cap: JP¥260.5b

Together with subsidiaries, engages in the research and development, manufacture, and marketing of generic pharmaceuticals.

Towa Pharmaceutical

Market Cap: JP¥209.5b

Manufactures and sale ethical drugs in Japan.

Kissei Pharmaceutical

Market Cap: JP¥194.8b

Researches, develops, manufactures, and sells pharmaceutical products primarily in Japan.

GNI Group

Market Cap: JP¥177.1b

Engages in the research, development, manufacturing, and sale of pharmaceuticals and biomaterials in Japan, China, and the United States.

Kaken Pharmaceutical

Market Cap: JP¥157.0b

Produces, markets, and sells medical products, medical devices, and agrochemicals in Japan and internationally.

PeptiDream

Market Cap: JP¥156.5b

A biopharmaceutical company, engages in the discovery and development of constrained peptides, small molecules, and peptide-drug conjugate therapeutics.

SanBio

Market Cap: JP¥154.9b

Engages in the development, production, and sale of regenerative cell medicines for the central nervous system.

Takara Bio

Market Cap: JP¥137.4b

Engages in the businesses of reagents, equipment, contract services, and genetic medicine in Japan, China, the rest of Asia, the United States, Europe, and internationally.

Mochida Pharmaceutical

Market Cap: JP¥123.2b

Manufactures and sells pharmaceuticals and healthcare products in Japan.

Zeria Pharmaceutical

Market Cap: JP¥99.3b

Manufactures, sells, imports, and exports pharmaceuticals, non-pharmaceutical products, veterinary pharmaceuticals, agricultural and industrial chemicals, and reagents in Japan and internationally.

KYORIN Pharmaceutical

Market Cap: JP¥95.2b

Through its subsidiaries, researches and develops, manufactures, and sells ethical and generic drugs in Japan and internationally.

Nxera Pharma

Market Cap: JP¥92.4b

Operates as a biopharmaceutical company, engages in drug discovery and development in Japan, the United States, Germany, Switzerland, Bermuda, the United Kingdom, and internationally.

ASKA Pharmaceutical HoldingsLtd

Market Cap: JP¥77.6b

Through its subsidiaries, engages in the pharmaceutical, animal health, and other businesses in Japan.

Oncolys BioPharma

Market Cap: JP¥73.2b

Engages in the research, development, manufacturing, sale, and import of oncolytic viruses, drugs and medicines, and tumor diagnostic agents in Japan, the United States, and Asia.

JCR Pharmaceuticals

Market Cap: JP¥68.7b

Engages in the research, development, manufacture, import and export, and sale of pharmaceutical products, regenerative medicines, and drug substances in Japan.

Fuji Pharma

Market Cap: JP¥63.3b

Engages in the research and development, manufacture, and marketing of pharmaceutical products in Japan and internationally.

Shin Nippon Biomedical Laboratories

Market Cap: JP¥63.1b

A contract research organization, engages in the pharmaceutical development, transactional research, and medipolis businesses in Japan and internationally.

3-D Matrix

Market Cap: JP¥60.9b

3-D Matrix, Ltd. developing, manufacturing, and selling self-assembling peptide technology in Japan and internationally.

Cuorips

Market Cap: JP¥57.9b

Engages in the research, development, manufacture, commercialization, and sale of human iPS cell-derived cardiomyocyte sheets.

Healios K.K

Market Cap: JP¥49.5b

Engages in the research, development, manufacturing, and sale of cell therapy and regenerative medicine products in Japan, Europe, and the United States.

Heartseed

Market Cap: JP¥44.0b

Develops and commercializes iPS cell-derived cardiomyocyte replacement therapy for heart failure.

Seikagaku

Market Cap: JP¥41.3b

Manufactures and sells pharmaceuticals and medical devices primarily related to glycoconjugates in Japan and internationally.